Executive Board

The Executive Board is responsible for managing the company. Its members are jointly accountable for the management of the company. The Executive Board has, as its prime responsibility, the group's strategic management, resource allocation, financial accounting and reporting, risk management, and corporate control.

Dr. Andreas Eckert
Chairman of the Executive Board
Dr. Andreas Eckert (born 1960) completed his academic studies in Heidelberg, New York and Berlin. After graduating with a Dr. phil. degree in Heidelberg, he worked for the Secretary-General of the United Nations as an Information Officer in New York, Latin America, Asia and Africa. Dr. Eckert returned to Berlin after the German reunification as an independent management consultant. He then founded the Eckert & Ziegler Strahlen- und Medizintechnik AG as well as other technology organisations predominantly involved in the life science branches.

Dr. Harald Hasselmann
Member of the Executive Board
Segment Medical (Distribution)

Dr. Harald Hasselmann (born 1967)
After completing his doctorate studies in economics he gained experience at various international pharmaceutical companies. He was head of controlling for Europe at Bayer Pharma, managing director at Schering’s Hungarian subsidiary and director of the Berlin-based biotech company metaGen. He has held various positions in large and medium-sized healthcare companies and has an excellent track record in sales, controlling and implementing restructuring measures. With effect from October 1, 2015, Dr. Harald Hasselmann became Managing Director for Sales and Finances at Eckert & Ziegler BEBIG. In January 2017 he was recruited as a member of the Executive Board of Eckert & Ziegler.

Dr. Lutz Helmke
Member of the Executive Board
Segment Medical (Operations)
Dr. Lutz Helmke (born 1961)
After graduating from Radio Chemistry studies and receiving his PhD, he switched into the medical device industry and started his career in the marketing department of Biotronik. After that, he held over a period of 25 years various management positions at Abbott, St. Jude Medical, and most recently MagForce. As head of various task forces within the German Medical Technology Association BVMed, Dr. Helmke also gained a wide range of experience in market launches and reimbursement aspects of medical devices. In September 2018 Dr. Helmke was appointed to the Executive Board of Eckert & Ziegler.

Jutta Ludwig
Member of the Executive Board
Asia Business

Jutta Ludwig, (born 1953)
After studying economics and sinology in Hamburg and Taiwan, Ms. Ludwig held various positions in German-Chinese economic cooperation. She was the managing director of the German Chamber of Commerce Abroad in Beijing for many years. She is a proven expert in business and economic policy cooperation with China and Asia. As of January 2023, Ms. Ludwig will be responsible for the Group's Asian Business on the Executive Board of Eckert & Ziegler AG.

Dr. Hakim Bouterfa
Member of the Executive Board
Head of Clinical Development

Dr. Hakim Bouterfa, (born 1962)
After studying human biology in Marburg and obtaining his PhD in Göttingen, Dr. Bouterfa worked as a scientist, among others in San Diego and Würzburg. He also held various positions in clinical research at Novartis AG and was a founder and managing director of R&D companies. Dr. Bouterfa is a highly experienced medical researcher in oncology with more than 20 years of clinical development experience. As of January 2023, he will be responsible for the Group's clinical development acting as the Chief Medical Officer.